→
Colloque

Novel Therapies for Monogenic Diseases

→
    du au
    Voir aussi :

    Documents et médias

    Programme

    Genome Engineering with CRISPR-Cas9: Biology, Mechanisms and Applications in Medicine
    Emmanuelle Charpentier

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    Gene Therapy of Primary Immunodeficiencies (PID)
    Alain Fischer

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    Genetic Engineering of Human Hematopoiesis for the Treatment of Inherited Diseases and Cancer
    Luigi Naldini

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    Gene Therapy of Hemophilias
    Amit Nathwani

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    New Mutation-Specific Pharmacotherapies for Cystic Fibrosis
    Kris de Boeck

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    Added Value of New Genomics Technologies in Undiagnosed Patients Who May Benefit from Known Therapies
    Judith Melki

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    From Promising Clinical Studies to Recent Clinical Trials for the Fragile X Mental Retardation Syndrome: The Challenge of Judging Efficacy
    Vincent des Portes

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    The Discovery and Development of Olesoxime for Spinal Muscular Atrophy Therapy
    Rebecca Pruss

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    From Gene Identification to Functional Analysis and Treatment of Achondroplasia
    Laurence Legeai-Mallet

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    Inhibition of Thromboxane Synthase, a New Mechanism to Increase Bone Density?
    Valerie Cormier-Daire

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    Selected Oral Communications: Drug Screening on Hutchinson Gilford Progeria Using Pluripotent Stem Cells Reveals New Pharmacological Modulators of Prelamin a Farnesylation
    Xavier Nissan

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    Novel Approaches for Treatment of Retinal Diseases
    José-Alain Sahel

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    Gene Replacement Therapy for Myotubular Myopathy
    Anna Buj Bello

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    REPS1 Is a Novel Gene of Neurodegeneration with Brain Iron Accumulation
    Arnold Munnich

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    Efficient AAV Gene Therapy in Cardiac and Neurological Murine Models for Friedreich Ataxia
    Hélène Puccio

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    Selected Oral Communication: High Expression and Therapeutic Efficiency of Systemic Delivery of a Dual AAV Strategy in a Murine Model for Dysferlin Deficiencies
    William Lostal

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    Selected Oral Communication: Gene Therapy for Alzheimer's Disease: The Cholesterol Connection
    Nathalie Cartier

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    Round Table: Can We Afford Cost of Innovative Therapies for Rare Diseases?
    Franck Dufour et Serge Braun

    -
    Non enregistré
    Colloque
    Novel Therapies for Monogenic Diseases
    Amphithéâtre Maurice-Halbwachs, Site Marcelin-Berthelot
    -

    Voir aussi

    Alain Fischer, chaire Médecine expérimentale
    Jean-Louis Mandel, chaire Génétique humaine